Germany provides US$59 million for development of COVID-19 therapeutics

German Minister of Education and Research, Anja Karliczek, has announced a new program amounting to €50 million (US$59 million) to strengthen the development of drugs and other therapeutics against the COVID-19 virus. The program specifically aims to support the clinical test phase, in which the safety and effectiveness of a new treatment are tested.

In addition to the availability of vaccines, effective therapeutics against COVID-19 are decisive in successfully fighting the pandemic, Karliczek said. Even with a high vaccination rate, people will continue to get infected with COVID-19, which is why therapy options for the various stages of infection are pivotal.

German companies and researchers with an operational site in Germany are eligible to apply for the funding provided.

Press release – Federal Ministry of Education and Research (in German)